Synapse Open Synapse
Biology

Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial

BioPharma Dive · · 2 min read

The better-than-expected results could make Epkinly the new “undisputed” treatment standard in newly diagnosed DLBCL, according to one analyst.

Latest from BioPharma Dive